GAVI Alliance Builds On Matching Fund On Heels Of Pfizer And GSK Vaccine Deal For Developing Countries

By Alfred Romann / Email the Author / PharmAsia News Jan. 27, 2012 6:00 PM GMT
Other Emerging Markets / Word Count: 755 / Article # 28120123017

Executive Summary

GAVI brings on new funding partners for immunization, supplementing expanded pneumococcal vaccine supply agreements with Pfizer and GSK.

Purchase this Article

$50.00 Buy Now

For $50.00, purchase this 755-word article and receive immediate online access. 100% Satisfaction Guarantee.

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

+ Show All | – Hide All

Offers & Events

Topics Covered in this Article

Click a keyword for related articles.
Subjects
Deals & Dealmaking Strategies
Business Models
Industries
Biopharmaceuticals
Vaccines
Therapeutic Categories
Respiratory
Pulmonary
Pneumonia
Regions
Africa
Companies
Pfizer Inc.
GlaxoSmithKline PLC

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: GAVI Alliance Builds On Matching Fund On Heels Of Pfizer And GSK Vaccine Deal For Developing Countries

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to PharmAsia News will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel